Structures by: Guralskiy I. A.
Total: 62
0.5(C16H8Ag4Fe2N12),0.5(C4H6N2)
0.5(C16H8Ag4Fe2N12),0.5(C4H6N2)
New J. Chem. (2016) 40, 11 9012
a=6.734(4)Å b=12.536(6)Å c=9.120(5)Å
α=90° β=118.622(10)° γ=90°
C20H12FeN8Pd
C20H12FeN8Pd
Dalton transactions (Cambridge, England : 2003) (2020) 49, 16 5302-5311
a=7.0962(7)Å b=7.1676(7)Å c=10.1546(16)Å
α=71.083(11)° β=74.381(11)° γ=89.881(8)°
C20H12FeN8Pt
C20H12FeN8Pt
Dalton transactions (Cambridge, England : 2003) (2020) 49, 16 5302-5311
a=7.2754(8)Å b=7.4315(9)Å c=10.3903(14)Å
α=72.230(11)° β=70.501(11)° γ=89.988(10)°
C20H12FeN8Pt
C20H12FeN8Pt
Dalton transactions (Cambridge, England : 2003) (2020) 49, 16 5302-5311
a=7.1262(5)Å b=7.1724(5)Å c=10.1727(8)Å
α=71.020(7)° β=75.175(6)° γ=89.950(6)°
C20H12Ag2FeN8
C20H12Ag2FeN8
Chemical Communications (2019)
a=14.4739(8)Å b=13.8064(7)Å c=20.7510(11)Å
α=90° β=90° γ=90°
C20H12Ag2FeN8
C20H12Ag2FeN8
Chemical Communications (2019)
a=15.1721(15)Å b=14.0669(12)Å c=21.086(2)Å
α=90° β=90° γ=90°
C18H16Br2FeN10
C18H16Br2FeN10
Journal of Materials Chemistry C (2018) 6, 13 3352
a=8.707(3)Å b=14.128(4)Å c=16.875(5)Å
α=90° β=90° γ=90°
C18H16Br2FeN10
C18H16Br2FeN10
Journal of Materials Chemistry C (2018) 6, 13 3352
a=7.3304(5)Å b=7.7934(5)Å c=18.5912(14)Å
α=90° β=97.229(3)° γ=90°
2(C9H8BrFe0.5N5)
2(C9H8BrFe0.5N5)
Journal of Materials Chemistry C (2018) 6, 13 3352
a=8.8257(8)Å b=13.4735(12)Å c=17.2070(16)Å
α=90° β=90° γ=90°
C18H16Br2FeN10
C18H16Br2FeN10
Journal of Materials Chemistry C (2018) 6, 13 3352
a=7.3713(8)Å b=7.8546(7)Å c=18.749(2)Å
α=90° β=97.334(4)° γ=90°
C18H16Br2FeN10
C18H16Br2FeN10
Journal of Materials Chemistry C (2018) 6, 13 3352
a=8.7376(19)Å b=12.499(2)Å c=19.217(4)Å
α=90° β=93.267(8)° γ=90°
C18H16Br2FeN10
C18H16Br2FeN10
Journal of Materials Chemistry C (2018) 6, 13 3352
a=8.7407(9)Å b=12.4108(13)Å c=19.0055(19)Å
α=90° β=94.212(4)° γ=90°
2(C18H16Br2FeN10)
2(C18H16Br2FeN10)
Journal of Materials Chemistry C (2018) 6, 13 3352
a=8.8548(5)Å b=12.5141(7)Å c=19.2074(11)Å
α=90° β=93.534(2)° γ=90°
Silver(i) Perchlorate 4:5 Complex with Pyridazino(4,5- d)pyridazine
(C30H20Ag4N20),4(ClO4)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0076(10)Å b=17.0076(10)Å c=7.8591(5)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Trifluorometanesulfonate Complex with Pyridazino(4,5-d)pyridazine, Solvate with 0.33 Water
C18H14Ag3N12O,3(CF3O3S)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=15.6887(9)Å b=15.6887(9)Å c=24.4805(18)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Hexaflurosilicate Tetrafluoroborate Complex with Pyridazino(4,5-d)pyridazine Hydrate
2(C15H10Ag2N10),F6Si,2(BF4),4(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=17.0801(11)Å b=17.0782(11)Å c=7.5920(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(NO3)
Dalton Transactions (2009) 15 2856-2864
a=7.7351(7)Å b=10.8172(8)Å c=7.1540(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate complex with 1,2,4,5-tetrazine
(C2H2N4),Ag,(ClO4)
Dalton Transactions (2009) 15 2856-2864
a=8.4650(7)Å b=10.4250(11)Å c=7.7750(6)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Nitrate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
(C4H6N4),2Ag,2(NO3)
Dalton Transactions (2009) 15 2856-2864
a=9.0359(8)Å b=13.2071(13)Å c=8.7513(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Perchlorate 2:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine, Dihydrate
(C4H6N4),2Ag,2(ClO4),2(H2O)
Dalton Transactions (2009) 15 2856-2864
a=6.7481(8)Å b=7.9981(9)Å c=8.1382(10)Å
α=65.302(11)° β=65.663(10)° γ=66.151(11)°
Copper(i) chloride 4:1 complex with 3,6-dimethyl-1,2,4,5- tetrazine
C4H6N4,4(CuCl)
Dalton Transactions (2009) 15 2856-2864
a=6.8143(9)Å b=6.2582(8)Å c=13.6220(17)Å
α=90.00° β=98.907(4)° γ=90.00°
Silver(i) Triflate 3:1 complex with 2,6-dimethyl-1,2,4,5- tetrazine, dihydrate
2(C4H6N4),6Ag,6(CF3O3S),4(H2O)
Dalton Transactions (2009) 15 2856-2864
a=10.5847(9)Å b=19.0579(13)Å c=23.1327(14)Å
α=90.00° β=102.038(10)° γ=90.00°
Copper(ii) acetate 2:1 complex with 4,4'-Bipyridazine, Dihydrate
C8H9CuN2O4,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=7.4144(9)Å b=8.2275(9)Å c=10.9023(13)Å
α=76.965(14)° β=82.505(13)° γ=63.267(13)°
Zinc(ii) Nitrate 1:1 Complex with 4,4'-Bipyridazine
C8H6N6O6Zn
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.07500(10)Å b=16.9431(3)Å c=11.9592(2)Å
α=90.00° β=101.3800(10)° γ=90.00°
Copper(ii) Dithionate 1:2 Complex with 4,4'-Bipyridazine, Dihydrate
C16H16CuN8O2,O6S2
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.1065(13)Å b=11.8885(9)Å c=11.0631(10)Å
α=90.00° β=90.00° γ=90.00°
Copper(ii) Trifluoroacetate 2:3 Complex with 4,4'-Bipyridazine
C32H18CU2F12N12O8
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.4940(6)Å b=10.9798(8)Å c=18.3058(13)Å
α=90.00° β=98.572(5)° γ=90.00°
Copper(ii) Tetrafluoroborate 1:2 Complex with 4,4'- Bipyridazine, Solvate with 3.33 Water
C48H36Cu3N24O4,6(BF4),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=12.0861(8)Å b=14.6555(8)Å c=21.5673(15)Å
α=90.00° β=104.025(8)° γ=90.00°
Dihydroxotricopper(ii) Trifluoroacetate Complex with 4,4'- Bipyridazine, Tetrahydrate
(C28H24Cu3F6N12O8),2(C2F3O2),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=15.4234(9)Å b=15.7761(12)Å c=19.1034(12)Å
α=90.00° β=108.591(6)° γ=90.00°
Copper(i) Chloride 2:1 Complex with 4,4'-Bipyridazine
C8H6CL2CU2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.617(2)Å b=13.132(4)Å c=6.642(2)Å
α=90.00° β=114.23(2)° γ=90.00°
Copper(i) Bromide 2:1 Complex with 4,4'-Bipyridazine
C8H6Br2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=6.712(2)Å b=13.450(4)Å c=6.807(3)Å
α=90.00° β=112.79(3)° γ=90.00°
Copper(i) Iodide 2:1 Complex with 4,4'-Bipyridazine
C8H6Cu2I2N4
Dalton transactions (Cambridge, England : 2003) (2007) 29 3140-3148
a=10.1405(5)Å b=10.1405(5)Å c=11.9784(7)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Hexafluorosilicate 2:3 Complex with Pyridazino(4,5- d)pyridazine, Decahydrate
C18H20Ag4N12O4,2(F6Si),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.85070(10)Å b=17.2093(3)Å c=12.0859(2)Å
α=90.00° β=100.7850(10)° γ=90.00°
Silver(i) Trifluoroacetate Complex with Pyridazino(4,5- d)pyridazine
C8H4AgF3N4O2
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.3514(2)Å b=12.5897(3)Å c=11.3054(3)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Pentafluoropropionate 2:1 Complex with Pyridazino(4,5-d)pyridazine
C12H4Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=25.2810(10)Å b=25.2810(10)Å c=7.4007(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Hexafluorosilicate 2:3 Complex with 4,4'- Bipyridazine, Trihydrate
C24H22Ag4N12O2,2(F6Si),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=7.7384(2)Å b=38.1690(8)Å c=50.8067(10)Å
α=90.00° β=90.00° γ=90.00°
Silver(i) Tetrafluoroborate 4:3 Complex with 4,4'- Bipyridazine Hydrate
(C24H18Ag4N12),4(BF4),(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=10.6823(8)Å b=12.1323(7)Å c=14.6844(9)Å
α=90.00° β=97.017(8)° γ=90.00°
Silver(i) Trifluoromethylsulfonate Complex with 4,4'- Bipyridazine, Solvate with 2/3 Water
C24H20Ag3N12O,3(CF3O3S),H2O
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=8.7652(6)Å b=22.1004(15)Å c=10.4417(7)Å
α=90.00° β=91.8740(10)° γ=90.00°
Silver(i) Heptafluorobutyrate 2:1 Complex with 4,4'- Bipyridazine
C16H6Ag2F14N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=28.4273(11)Å b=28.4273(11)Å c=7.5353(3)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Pentafluoropropionate 2:1 Complex with 4,4'- Bipyridazine
C14H6Ag2F10N4O4
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=26.9862(12)Å b=26.9862(12)Å c=7.6176(4)Å
α=90.00° β=90.00° γ=120.00°
Silver(i) Trifluoroacetate 2:1 Complex with 4,4'- Bipyridazine, Solvate with 2/7 Chloroform
C84H42Ag14F42N28O28,2(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2007) 35 3893-3905
a=13.9023(2)Å b=14.4405(3)Å c=18.2666(2)Å
α=107.0790(10)° β=111.5920(10)° γ=94.2320(10)°
C20H12FeN8Pd
C20H12FeN8Pd
Dalton transactions (Cambridge, England : 2003) (2020) 49, 16 5302-5311
a=7.2433(4)Å b=7.4455(4)Å c=10.4263(9)Å
α=71.858(6)° β=69.586(6)° γ=89.943(5)°
<i>catena</i>-Poly[[[diaqua[1,2-bis(pyridin-4-yl)ethene]{4-[2-(pyridin-4-yl)ethenyl]pyridinium}gold(I)iron(II)]-di-μ-cyanido] bis[dicyanidogold(I)] 1,2-bis(pyridin-4-yl)ethene dihydrate]
C30H25Au3FeN10O2,C12H10N2,2(H2O)
Acta Crystallographica Section E Crystallographic Communications (2020) 76, 6 944
a=10.5601(7)Å b=11.0044(12)Å c=11.8145(10)Å
α=80.212(8)° β=69.124(7)° γ=78.565(7)°
<i>catena</i>-Poly[[[(2-ethoxypyrazine-κ<i>N</i>)copper(I)]-di-μ~2~-cyanido] [copper(I)-μ~2~-cyanido]]
C8H8Cu2N4O
Acta Crystallographica Section E (2019) 75, 11 1797-1800
a=26.840(5)Å b=4.8300(10)Å c=18.620(4)Å
α=90° β=119.91(3)° γ=90°
Poly[[diaquatetra-μ~2~-cyanido-iron(II)platinum(II)] acetone disolvate]
C4H4FeN4O2Pt,2(C3H6O1)
Acta Crystallographica Section E (2019) 75, 10 1536-1539
a=7.4802(4)Å b=7.4802(4)Å c=7.9725(11)Å
α=90° β=90° γ=90°
Poly[bis(μ-2-bromopyrazine)tetra-μ~2~-cyanido-dicopper(I)iron(II)]
C12H6Br2Cu2FeN8
Acta Crystallographica Section E (2018) 74, 12 1895-1898
a=13.6143(17)Å b=9.3067(11)Å c=13.2101(15)Å
α=90° β=92.369(4)° γ=90°
<i>fac</i>-Triaquatris(thiocyanato-κ<i>N</i>)iron(III)—–2,3-dimethylpyrazine (1/3)
C3H6Fe1N3O3S3,3(C6H8N2)
Acta Crystallographica Section E (2015) 71, 4 374-376
a=16.9383(12)Å b=16.9383(12)Å c=17.6259(13)Å
α=90° β=90° γ=120°
Poly[di-μ~3~-cyanido-di-μ~2~-cyanido-bis(μ~2~-2-ethylpyrazine)dicopper(I)iron(II)]
0.25(C64H64Cu8Fe4N32)
Acta Crystallographica Section E (2019) 75, 8 1205-1208
a=13.1997(17)Å b=9.2923(11)Å c=13.8010(17)Å
α=90° β=92.399(2)° γ=90°
<i>catena</i>-Poly[[gold(I)-μ-cyanido-[diaquabis(2-phenylpyrazine)iron(II)]-μ-cyanido] dicyanidogold(I)]
C22H20AuFeN6O2,AuC2N2
Acta Crystallographica Section E (2019) 75, 8 1149-1152
a=18.5306(13)Å b=10.4541(3)Å c=14.2522(9)Å
α=90° β=107.509(7)° γ=90°
<i>catena</i>-Poly[[[tetraaquairon(II)]-<i>trans</i>-μ-1,2-bis(pyridin-4-yl)ethene-κ^2^<i>N</i>:<i>N</i>] bis(<i>p</i>-toluenesulfonate) methanol disolvate]
C12H18FeN2O4,2(C7H7O3S),2(CH4O)
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1977-1980
a=13.8416(9)Å b=7.7686(4)Å c=16.4076(13)Å
α=90° β=111.845(9)° γ=90°
Poly[tetra-μ-cyanido-ethanolbis(2-iodopyrazine)digold(I)iron(II)]
C14H12Au2FeI2N8O
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 11 1755-1758
a=9.40(2)Å b=10.30(2)Å c=12.81(3)Å
α=92.05(6)° β=99.67(7)° γ=114.30(6)°
Poly[[aqua-μ~4~-pyridazino[4,5-d]pyridazine-μ~3~-sulfato-disilver(I)] monohydrate]
C6H6Ag2N4O5S,H2O
Acta Crystallographica Section C (2007) 63, 6 m259-m263
a=8.3733(2)Å b=8.7790(2)Å c=8.9006(3)Å
α=85.9270(10)° β=74.334(2)° γ=68.8160(10)°
Poly[[μ~4~-4,4-bipyridazine-μ~5~-sulfato-disilver(I)] monohydrate]
C8H6Ag2N4O4S,H2O
Acta Crystallographica Section C (2007) 63, 6 m259-m263
a=7.4829(9)Å b=8.4881(10)Å c=10.9267(10)Å
α=67.172(9)° β=88.971(8)° γ=67.092(8)°
Poly[di-μ-chlorido-μ-(4,4-bipyridazine)-κ^2^<i>N</i>^1^:<i>N</i>^1'^- cadmium(II)]
C8H6CdCl2N4
Acta Crystallographica Section C (2012) 68, 11 m295-m299
a=11.7374(10)Å b=11.6511(10)Å c=7.5484(8)Å
α=90.00° β=90.00° γ=90.00°
Poly[di-μ-bromido-μ-(4,4-bipyridazine)-κ^2^<i>N</i>^1^:<i>N</i>^1'^- cadmium(II)]
C8H6Br2CdN4
Acta Crystallographica Section C (2012) 68, 11 m295-m299
a=11.7549(8)Å b=11.9619(8)Å c=7.8690(6)Å
α=90.00° β=90.00° γ=90.00°
Poly[[tetra-μ-iodido-μ~4~-(4,4-bipyridazine)- κ^4^<i>N</i>^1^:<i>N</i>^2^:<i>N</i>^1'^:<i>N</i>^2'^-dicadmium(II)]
C8H6Cd2I4N4
Acta Crystallographica Section C (2012) 68, 11 m295-m299
a=8.0106(6)Å b=14.3621(13)Å c=7.6850(6)Å
α=90.00° β=115.855(8)° γ=90.00°
Pyridinium bis(pyridine-κ<i>N</i>)tetrakis(thiocyanato-κ<i>N</i>)ferrate(III)
C5H6NC14H10FeN6S4
Acta Crystallographica Section E (2013) 69, 6 m298-m299
a=10.7650(7)Å b=14.0424(8)Å c=15.7266(9)Å
α=90.00° β=103.244(3)° γ=90.00°
Pyridinium bis(pyridine-κ<i>N</i>)tetrakis(thiocyanato-κ<i>N</i>)ferrate(III)—–pyrazine-2-carbonitrile—–pyridine (1/4/1)
C5H6N,C14H10FeN6S4,4(C5H3N3),C5H5N
Acta Crystallographica Section E (2013) 69, 5 m280
a=8.1766(2)Å b=11.9362(3)Å c=12.7519(3)Å
α=102.9820(10)° β=97.7990(10)° γ=97.6840(10)°
C12H6Cl2FeN8Ni
C12H6Cl2FeN8Ni
Inorganic chemistry (2016) 55, 10 4906-4914
a=16.511(2)Å b=6.9222(10)Å c=7.2033(7)Å
α=90° β=112.050(12)° γ=90°
C8H5FeIN6OPt
C8H5FeIN6OPt
Inorganic chemistry (2016) 55, 10 4906-4914
a=12.91814(9)Å b=7.52763(6)Å c=13.28367(11)Å
α=90.00° β=90.00° γ=90.00°
C12H6Cl2FeN8Ni
C12H6Cl2FeN8Ni
Inorganic chemistry (2016) 55, 10 4906-4914
a=16.7053(11)Å b=7.1336(4)Å c=7.3280(3)Å
α=90° β=110.358(5)° γ=90°
C8H5FeIN6OPd
C8H5FeIN6OPd
Inorganic chemistry (2016) 55, 10 4906-4914
a=12.9755(2)Å b=7.53780(13)Å c=13.2172(3)Å
α=90.00° β=90.00° γ=90.00°
C8H5FeIN6NiO
C8H5FeIN6NiO
Inorganic chemistry (2016) 55, 10 4906-4914
a=12.7324(5)Å b=7.3646(3)Å c=12.9803(5)Å
α=90° β=90° γ=90°